These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 16626319
1. [Intraoperative labeling of sentinel lymph nodes with a combination of vital dye and radionuclide tracer--results in sentinel lymph node-positive patients]. Pfützner W, Kunte C, Weiss M, Flaig MI, Konz B. J Dtsch Dermatol Ges; 2006 Mar; 4(3):229-35. PubMed ID: 16626319 [Abstract] [Full Text] [Related]
2. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? McMasters KM, Reintgen DS, Ross MI, Wong SL, Gershenwald JE, Krag DN, Noyes RD, Viar V, Cerrito PB, Edwards MJ. Ann Surg Oncol; 2001 Apr; 8(3):192-7. PubMed ID: 11314933 [Abstract] [Full Text] [Related]
3. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes? Vidal-Sicart S, Pons F, Puig S, Ortega M, Vilalta A, Martín F, Rull R, Palou JM, Castel T. Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963 [Abstract] [Full Text] [Related]
4. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and isosulfan blue dye injection. Martínez-Palones JM, Gil-Moreno A, Pérez-Benavente MA, Roca I, Xercavins J. Gynecol Oncol; 2004 Mar; 92(3):845-50. PubMed ID: 14984951 [Abstract] [Full Text] [Related]
5. A randomized study comparing the effectiveness of methylene blue dye with lymphazurin blue dye in sentinel lymph node biopsy for the treatment of cutaneous melanoma. Liu Y, Truini C, Ariyan S. Ann Surg Oncol; 2008 Sep; 15(9):2412-7. PubMed ID: 18581184 [Abstract] [Full Text] [Related]
6. Sentinel node localization in primary melanoma: preoperative dynamic lymphoscintigraphy, intraoperative gamma probe, and vital dye guidance. Gennari R, Bartolomei M, Testori A, Zurrida S, Stoldt HS, Audisio RA, Geraghty JG, Paganelli G, Veronesi U. Surgery; 2000 Jan; 127(1):19-25. PubMed ID: 10660754 [Abstract] [Full Text] [Related]
7. Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Sondak VK, King DW, Zager JS, Schneebaum S, Kim J, Leong SP, Faries MB, Averbook BJ, Martinez SR, Puleo CA, Messina JL, Christman L, Wallace AM. Ann Surg Oncol; 2013 Feb; 20(2):680-8. PubMed ID: 23054107 [Abstract] [Full Text] [Related]
8. Validation of delayed sentinel lymph node mapping for melanoma. Kalady MF, White DC, Fields RC, Coleman RE, Schuler FR, Seigler HF, Tyler DS. Cancer J; 2001 Feb; 7(6):503-8. PubMed ID: 11769863 [Abstract] [Full Text] [Related]
9. The application of sentinel node radiolocalization to solid tumors of the head and neck: a 10-year experience. Alex JC. Laryngoscope; 2004 Jan; 114(1):2-19. PubMed ID: 14709988 [Abstract] [Full Text] [Related]
10. Hot or not? The 10% rule in sentinel lymph node biopsy for malignant melanoma revisited. Murphy AD, Britten A, Powell B. J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):316-9. PubMed ID: 24290978 [Abstract] [Full Text] [Related]
11. Intraoperative lymphatic mapping for early-stage melanoma of the head and neck. Bostick P, Essner R, Sarantou T, Kelley M, Glass E, Foshag L, Stern S, Morton D. Am J Surg; 1997 Nov; 174(5):536-9. PubMed ID: 9374232 [Abstract] [Full Text] [Related]
12. Prevalence of additional positive lymph nodes in complete lymphadenectomy specimens after positive sentinel lymphadenectomy findings for early-stage melanoma of the head and neck. Pu LL, Wells KE, Cruse CW, Shons AR, Reintgen DS. Plast Reconstr Surg; 2003 Jul; 112(1):43-9. PubMed ID: 12832875 [Abstract] [Full Text] [Related]
13. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node. Argon AM, Duygun U, Acar E, Daglioz G, Yenjay L, Zekioglu O, Kapkac M. Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076 [Abstract] [Full Text] [Related]
14. [Intraoperative detection of sentinel lymph nodes in cutaneous malignant melanoma -- blue dye alone versus blue dye plus gamma detection]. Kretschmer L, Peeters S, Beckmann I, Thoms KM, Mitteldorf C, Emmert S, Sahlmann CO, Bertsch HP, Neumann C, Meller J. J Dtsch Dermatol Ges; 2005 Aug; 3(8):615-22. PubMed ID: 16033480 [Abstract] [Full Text] [Related]
15. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer. Carmon M, Olsha O, Rivkin L, Spira RM, Golomb E. Breast J; 2006 Aug; 12(3):199-201. PubMed ID: 16684315 [Abstract] [Full Text] [Related]
16. Temporary shielding of hot spots in the drainage areas of cutaneous melanoma improves accuracy of lymphoscintigraphic sentinel lymph node diagnostics. Maza S, Valencia R, Geworski L, Zander A, Dräger E, Winter H, Sterry W, Munz DL. Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1399-402. PubMed ID: 12271426 [Abstract] [Full Text] [Related]
17. [Sentinel lymph node identification in the staging of cutaneous melanoma. Blue dye vs. radioguided localization]. Gesuelli GC, Sartelli M, Berbellini A, Brianzoni E, Simonacci M, Sigona M. Minerva Chir; 2000 Oct; 55(7-8):513-6. PubMed ID: 11140105 [Abstract] [Full Text] [Related]
18. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer. Kumar R, Jana S, Heiba SI, Dakhel M, Axelrod D, Siegel B, Bernik S, Mills C, Wallack M, Abdel-Dayem HM. J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869 [Abstract] [Full Text] [Related]
19. The role of selective lymphadenectomy in the management of patients with malignant melanoma. Glass LF, Fenske NA, Messina JL, Cruse CW, Rapaport DP, Berman C, Puleo CA, Heller R, Miliotes G, Albertini J. Dermatol Surg; 1995 Nov; 21(11):979-83. PubMed ID: 7582838 [Abstract] [Full Text] [Related]
20. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma. Reintgen D, Rapaport D, Tanabe KK, Ross M. J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171 [Abstract] [Full Text] [Related] Page: [Next] [New Search]